iCAD, Inc. (ICAD)
NASDAQ: ICAD · IEX Real-Time Price · USD
1.300
-0.060 (-4.41%)
At close: Jul 19, 2024, 4:00 PM
1.380
+0.080 (6.15%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Company Description
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States.
It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.
The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
iCAD, Inc.
| Country | United States |
| Founded | 1984 |
| IPO Date | Dec 3, 1986 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 69 |
| CEO | Ms. Dana R. Brown |
Contact Details
Address: 98 Spit Brook Road, Suite 100 Nashua, New Hampshire 03062 United States | |
| Phone | 603-882-5200 |
| Website | icadmed.com |
Stock Details
| Ticker Symbol | ICAD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000749660 |
| CUSIP Number | 44934S206 |
| ISIN Number | US44934S2068 |
| Employer ID | 02-0377419 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dana R. Brown | President, Chief Executive Officer and Executive Chair |
| Jonathan Go | Chief Technology Officer |
| Eric Lonnqvist | Chief Financial Officer |
| Michelle Strong | Chief Operations Officer |
| Annette L. Heroux | Vice President of Administration |
| Anthony Takazawa | Director of Investor Relations |
| Brian Testa | Chief People Officer |
| Bill Keyes | Senior Vice President of Global Sales Operations |
| Vasu Avadhanula | Chief Product Officer |
| Peter Graham | Senior Vice President of North American Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 2, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 14, 2024 | 8-K | Current Report |
| May 15, 2024 | 8-K | Current Report |
| May 15, 2024 | 10-Q | Quarterly Report |
| Apr 29, 2024 | DEF 14A | Other definitive proxy statements |
| Mar 29, 2024 | 10-K | Annual Report |
| Mar 12, 2024 | 8-K | Current Report |
| Feb 26, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 25, 2024 | 8-K | Current Report |